https://astralcodexten.substack.com/p/addendum-to-luvox-post

In my post yesterday, I quoted a Vox article describing work by Dr. Ed Mills and others to get the FDA to approve Luvox for COVID. As of that point, the FDA didn't know how to process an application without a sponsoring drug company:

[Professor Ed] Mills, who thinks that fluvoxamine and budesonide are both appropriate to prescribe to patients sick with Covid-19, compares public messaging on fluvoxamine to communications about Merck's drug molnupiravir. The evidence for molnupiravir is in many ways weaker than the evidence for fluvoxamine, but molnupiravir was produced by a major pharmaceutical company that can shepherd it through the process of becoming a recommended drug. On a call last week, Mills said, the FDA told him "they don't know how to deal with submissions where there isn't someone to be responsible for it."

But it looks like just as I published, he and his colleagues found a way around the problem: